Clinical trials
Other Cancer clinical trials
Below are recruiting other cancer clinical trials, each written for real people, not researchers. We’re tracking 13,118 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03818503Recruiting
Study of European radiotherapy infrastructure for cancer care
This study looks at how radiotherapy (radiation treatment for cancer) is planned and delivered across participating centers in Europe. If you may need radiotherapy, this research may help improve how cancer radiation care is organized and provided.
GrazAges 12 years+ - NCT03819751Recruiting
MRI-guided prostate biopsy: software vs visual matching
This study compares two ways of using prostate MRI images to guide a biopsy and check how accurately prostate cancer can be found. If you have MRI spots that may be cancer, the trial will help test whether computer software or a visual method works better.
Leuven, Vlaams-brabantAges 50–75 - NCT03824145Recruiting
Lifestyle coaching for women with metastatic breast cancer
This study tests a structured lifestyle program (diet and physical activity guidance) for women with metastatic breast cancer. It may help improve well-being and health behaviors, especially if you haven’t been following the recommended nutrition and activity guidelines.
Maywood, IllinoisAges 18 years+ - NCT03827317Recruiting
Scan to see HER2 in breast cancer with a new tracer
This study tests a new PET scan tracer to show where HER2-positive breast cancer cells may be in the body. It may help doctors better “map” HER2 activity, including in people with HER2-positive or HER2-negative cancer.
LondonAges 18 years+ - NCT03829553RecruitingPhase 3
Radiation to breast lymph nodes versus standard breast cancer care
This Phase 3 trial tests whether a shorter, more focused radiation treatment to the regional lymph nodes works as well as the current standard approach for certain breast cancers. It may help patients by potentially improving treatment efficiency while keeping cancer control effective.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT03829033Recruiting
Photon vs proton radiation for early tonsil cancer
This trial compares two types of radiation—photon therapy and proton therapy—for early-stage tonsil cancer. The goal is to see which approach works well for cure while affecting surrounding tissues differently.
GävleAges 18 years+ - NCT03830788Recruiting
Radiation options for early prostate cancer-related erections
This study compares two radiation treatments—seed brachytherapy and stereotactic body radiotherapy—to see which better preserves erections in men with early- to mid-risk prostate cancer. It’s designed to help patients understand how different curative radiation choices can affect sexual function.
AlbiAges 18 years+ - NCT03832361RecruitingPhase 2
Mirvetuximab for folate-receptor–positive endometrial cancer
This Phase 2 study tests mirvetuximab (a targeted antibody drug) in women whose endometrial cancer is positive for folate receptor-alpha. It aims to shrink tumors and improve outcomes, especially in cancer that has returned or kept growing after previous treatment.
New Haven, ConnecticutAges 18–100 - NCT03841617RecruitingPhase 2
Measure radiation in thyroid cancer using a special PET-CT scan
This trial tests how much radiation a specialized whole-body PET/CT scan delivers in patients with differentiated thyroid cancer. It may help doctors better plan treatment for cancer that persists, returns, or has spread—especially when radioactive iodine (RAI) may or may not work.
Bethesda, MarylandAges 18–90 - NCT03844399Recruiting
3D ultrasound imaging during liver or kidney procedures
This study uses a new 3D ultrasound scan while you get standard care for a liver or kidney biopsy or ablation. The goal is to see whether the imaging is clear and useful during these procedures.
London, OntarioAges 18 years+ - NCT03848052Recruiting
Study of lung cancer care in France since 2015
This trial tracks how lung cancer is treated in France, looking at what therapies were used and how care has evolved since 2015. It may help doctors improve future treatment choices by understanding real-world care patterns.
AngersAges 18 years+ - NCT03853915Recruiting
PET scan and HPV testing during chemoradiation for cervical cancer
This study looks at whether a PET scan (FDG-PET/CT) and blood HPV testing can help track cervical cancer responses during and after standard chemo-radiation. It may help doctors better understand who is responding and who may need different care.
Toronto, OntarioAges 18 years+ - NCT03857373Recruiting
Study testing a computer tool to detect kidney cancer after surgery
This trial is for people with renal (kidney) cancer who have already had surgery. The study is testing whether a computer method can use medical information from you to improve kidney-cancer detection.
RoskildeAges Any age - NCT03861676RecruitingEarly Phase 1
PET-guided targeted radiation for early prostate cancer
This early-phase study tests a precise, targeted radiation treatment for prostate cancer, using a special PET scan to help plan exactly where to treat. It may help reduce the amount of radiation to surrounding tissues while treating the cancer.
Baltimore, MarylandAges 18–100 - NCT03862677Recruiting
Testing immune markers to predict outcomes in ovarian cancer
This study looks at immune-related markers in people with ovarian cancer to see if they can help predict prognosis (how the cancer may behave). If you qualify, your doctors may use your immune test results alongside other standard treatments like surgery, chemotherapy, and/or immunotherapy.
LeidenAges 18 years+ - NCT03870620Recruiting
Register for metastatic breast cancer patients in Austria
This trial is a non-treatment registry that collects information about people with metastatic breast cancer in Austria. It may help researchers better understand the disease and outcomes over time by tracking real-world patient details.
Salzburg, State of SalzburgAges 18 years+ - NCT03874559Recruiting
Testing exosomes during treatment for rectal cancer
This trial studies “exosomes” (tiny cell signals being researched as a possible way to affect cancer treatment) in people with rectal cancer. You would receive standard chemotherapy plus radiation before planned surgery, and the trial looks at outcomes related to that treatment.
Kansas City, KansasAges 18 years+ - NCT03875716Recruiting
De-intensified radiation after surgery for HPV throat cancer
This trial studies a lower-intensity (less aggressive) course of radiation therapy after curative surgery for HPV-related tonsil or base-of-tongue cancer. The goal is to see if patients can still be treated successfully while reducing side effects from radiation.
Boston, MassachusettsAges 18 years+ - NCT03892993Recruiting
Decision aid for medullary thyroid cancer treatment choices
This study tests a patient-and-caregiver decision guide to help you decide when to start or stop a new cancer drug, join a clinical trial, or continue active surveillance. It aims to make tough choices feel clearer and more supported.
Houston, TexasAges 18 years+ - NCT03897270Recruiting
Breast cancer or healthy women for new breast imaging
This study tests a new way to look at the breast using photoacoustic imaging, alongside a breast MRI. It may help researchers see breast masses more clearly, even though it’s mainly for measuring how well the imaging works.
Buffalo, New YorkAges 18 years+ - NCT03914391Recruiting
Find new urine tests to screen for prostate cancer
This study looks for new urine markers (signals) that could help screen for prostate cancer. If you have a higher PSA blood test and are scheduled for a prostate biopsy, your urine sample may be studied to see if it can improve screening.
ShatinAges 18 years+ - NCT03926338RecruitingPhase 2
Before-surgery immunotherapy for MSI-H or dMMR colon cancer
This trial studies a treatment given before surgery using toripalimab, with or without celecoxib, for colon or rectal cancer that has MSI-H or dMMR tumor features. It aims to shrink or control the cancer before the operation and compare whether adding celecoxib helps.
Guangzhou, GuangdongAges 18–75 - NCT03925662RecruitingPhase 3
Mebendazole added to stage 4 colon cancer care
This trial studies whether adding mebendazole (an existing anti-parasite medicine) to standard treatment can improve outcomes for people with stage 4 colon cancer. You might qualify if you have stage 4 colorectal cancer and none of the key safety concerns.
CairoAges 18 years+ - NCT03932786Recruiting
Study of health and wellbeing after retinoblastoma treatment
This study looks at long-term health outcomes—how patients are doing physically and in daily life—after treatment for retinoblastoma. It may help doctors understand what support or follow-up care could be most helpful after treatment.
Chicago, IllinoisAges Any age
Hear when a new Other Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for other cancer?
- Yes. Clin2 currently lists 13,118 recruiting other cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a other cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a other cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.